Your session is about to expire
← Back to Search
Whole body vibration training for Neurologic Locomotion Disorder (CP_WBVT Trial)
N/A
Waitlist Available
Led By Jeffrey D Eggleston, PhD
Research Sponsored by University of Texas, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
CP_WBVT Trial Summary
This study is evaluating whether a four-week whole-body vibration training intervention can improve gait function in children with Cerebral Palsy.
Eligible Conditions
- Neurologic Locomotion Disorder
- Neurologic Gait Disorders
- Cerebral Palsy
CP_WBVT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Timed up and go test
Two-minute walk test
Secondary outcome measures
Lower extremity gait function
CP_WBVT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Vibration groupExperimental Treatment1 Intervention
This group will receive vibration stimulation while standing on a side-alternating vibration platform. Vibration sessions will occur three times per week over four-weeks. Each session will include three-minutes of vibration followed by three-minutes rest, completing this sequence three times per session
Group II: Control groupActive Control1 Intervention
This group will not receive vibration, but will rather hear a recording of the vibration, while still standing on the vibration platform. Still, this group will receive this training three times per week over four-weeks with a similar three-minute rotation as the vibration group.
Find a Location
Who is running the clinical trial?
University of Texas, El PasoLead Sponsor
13 Previous Clinical Trials
2,683 Total Patients Enrolled
Jeffrey D Eggleston, PhDPrincipal InvestigatorThe University of Texas at El Paso
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger